David J. Schlanger - Feb 11, 2022 Form 4 Insider Report for Progyny, Inc. (PGNY)

Role
Executive Chairman, Director
Signature
/s/ Jennifer Bealer, Attorney-in-Fact
Stock symbol
PGNY
Transactions as of
Feb 11, 2022
Transactions value $
-$41,090
Form type
4
Date filed
2/15/2022, 08:09 PM
Previous filing
Jan 5, 2022
Next filing
Feb 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PGNY Common Stock Options Exercise $910 +1K +1.19% $0.91* 85K Feb 11, 2022 Direct
transaction PGNY Common Stock Sale -$42K -1K -1.18% $42.00 84K Feb 11, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PGNY Employee Stock Option (Right to Buy) Options Exercise $0 -1K -0.05% $0.00 2.18M Feb 11, 2022 Common Stock 1K $0.91 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.0050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
F3 One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date.